VON RICKENBACH JOSEF H
Transaction: 05/27/2026
BUY
Change
+4,500
Price
$1.07
Filing
05/28/2026
Type
BUY
Rein Therapeutics Inc.
RNTX • Biotechnology
$0.89
▲ +0.05 (+5.39%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$59.64M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Weak liquidity · 0.7Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:15 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.89
Change5.39%
Shares Out67.08M
Market Cap$59.64M
Enterprise Value$19.00M
52W Range0.69 - 2.18
Beta1.37
P/E-1.20
P/B1.08
P/FCF-3.17
EV/EBITDA-0.92
EV/FCF-1.01
Price$0.89
Change5.39%
Shares Out67.08M
Market Cap$59.64M
Enterprise Value$19.00M
52W Range0.69 - 2.18
Beta1.37
P/E-1.20
P/B1.08
P/FCF-3.17
EV/EBITDA-0.92
EV/FCF-1.01
Earnings Yield-83.43%
FCF Yield-31.57%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.70
Quick Ratio0.70
Target$6.00
Target Upside574.84%
Target Median$6.00
Target Range6.00 - 6.00
Volume210.80K
Avg Volume816.45K
EPS Surprise0.30
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
24/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Manageable debt level · 0Weak liquidity · 0.7Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-09-05
75/100
Bullish
Bullish
1
Hold
1
Bearish
0
Price Target
2026-08-16
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
VON RICKENBACH JOSEF H
Transaction: 05/26/2026
BUY
Change
+23,190
Price
$1.06
Filing
05/28/2026
Type
BUY
VON RICKENBACH JOSEF H
Transaction: 05/22/2026
BUY
Change
+15,950
Price
$1.05
Filing
05/28/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| VON RICKENBACH JOSEF H | BUY | +4,500 | $1.07 | 05/27/2026 | 05/28/2026 |
| VON RICKENBACH JOSEF H | BUY | +23,190 | $1.06 | 05/26/2026 | 05/28/2026 |
| VON RICKENBACH JOSEF H | BUY | +15,950 | $1.05 | 05/22/2026 | 05/28/2026 |
| VON RICKENBACH JOSEF H | BUY | +3,420 | $1.04 | 05/21/2026 | 05/28/2026 |
| WINDSOR JAMES BRIAN | SELL | -150,000 | $1.17 | 05/08/2026 | 05/13/2026 |
| WINDSOR JAMES BRIAN | BUY | +25,000 | $1.00 | 04/30/2026 | 05/13/2026 |
| Voss Capital, LP | BUY | +104,183 | $1.22 | 11/14/2025 | 11/18/2025 |
| Voss Capital, LP | BUY | +178,392 | $1.39 | 10/28/2025 | 10/28/2025 |
| Voss Capital, LP | BUY | +4,840 | $1.37 | 10/27/2025 | 10/28/2025 |
| Voss Capital, LP | BUY | +30,176 | $1.39 | 10/24/2025 | 10/28/2025 |
| Voss Capital, LP | OTHER | 0 | Not reported | 09/24/2025 | 10/03/2025 |
| Ambros Reinhard J. | BUY | +17,500 | $1.55 | 07/23/2025 | 07/23/2025 |
| Fairey William | BUY | +17,500 | $1.55 | 07/23/2025 | 07/23/2025 |
| Musso Alan A | BUY | +17,500 | $1.55 | 07/23/2025 | 07/23/2025 |
| VON RICKENBACH JOSEF H | BUY | +17,500 | $1.55 | 07/23/2025 | 07/23/2025 |
| Aivado Manuel | BUY | +17,500 | $1.55 | 07/23/2025 | 07/23/2025 |